Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: Streptococcus vaccine and antibody therapeutics - Valneva

Next Previous
Drug Profile

Research programme: Streptococcus vaccine and antibody therapeutics - Valneva

Alternative Names: Group A Streptococcus antibodies - Intercell; Group A Streptococcus antibodies - Valneva; Group A Streptococcus vaccine - Intercell; Group A Streptococcus vaccine - Valneva; Group B Streptococcus antibodies - Intercell; Group B Streptococcus antibodies - Valneva

Latest Information Update: 01 Jul 2013

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Intercell
  • Developer Valneva
  • Class Monoclonal antibodies; Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Streptococcal infections

Most Recent Events

  • 01 Jul 2013 No development reported - Preclinical for Streptococcal infections in Austria (Parenteral)
  • 28 May 2013 Intercell has merged with Vivalis to form Valneva
  • 01 Sep 2010 Preclinical development is ongoing with Intercell
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top